Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Small Cell Carcinoma of Lung: early-phase trial registry

1 of 1 indexed Small Cell Carcinoma of Lung trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Small Cell Carcinoma of Lung: 1 US clinical trial tracked, 1 recruiting.

Small Cell Carcinoma of Lung is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Avacta Life Sciences, running 1 of these trials.

Enrollment posture brief

Registry condition small-cell-carcinoma-of-lung

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Small Cell Carcinoma of (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Small Cell Carcinoma of Lung

Small Cell Carcinoma of Lung lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Small Cell Carcinoma of Lung on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Small Cell Carcinoma of Lung is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Small Cell Carcinoma of Lung records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AVA6103 Drug
1 trials

US sites by state

Facility locations filed on Small Cell Carcinoma of Lung trials. A trial with sites in several states counts in each.

Virginia 1 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Small Cell Carcinoma of Lung page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Small Cell Carcinoma of Lung trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Avacta Life Sciences sponsors the most Small Cell Carcinoma of Lung trials on record, review their full trial history before evaluating a specific study. See Avacta Life Sciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Small Cell Carcinoma of Lung condition card totals 1 registered trials; most-linked intervention AVA6103; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.